- PARAGON-HF study (Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction)2020 | First Faculty of Medicine
- Global Differences in Heart Failure With Preserved Ejection Fraction : The PARAGON-HF Trial2021 | First Faculty of Medicine
- Baseline Characteristics of Patients With Heart Failure and Preserved Ejection Fraction in the PARAGON-HF Trial2018 | First Faculty of Medicine
- New views on pathophysiology, diagnostics and treatment of heart failure with preserved ejection fraction2016 | First Faculty of Medicine
- A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction2020 | First Faculty of Medicine
